Biogen Inc., 10% Owner at SANGAMO THERAPEUTICS, INC (SGMO), sold 255,984 shares at $8.52 ($2.2M) on 2021-12-07, disclosed to the SEC on 2021-12-09.
Open-market sale of $2.2M SGMO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.52 | 52,178 | $445K | 20.2% |
| 2 | $8.52 | 52,178 | $445K | 20.2% |
| 3 | $8.64 | 75,814 | $655K | 29.8% |
| 4 | $8.64 | 75,814 | $655K | 29.8% |
| Total | $8.59 avg | 255,984 | $2.2M | 100% |
| Filing → |
| SGMO | SELL | 2021-12-30 | $24K | — | Filing → |
| SGMO | SELL | 2021-12-28 | $1.4M | — | Filing → |
| SGMO | SELL | 2021-12-10 | $405K | — | Filing → |